10 Biggest Antidepressant Drug Companies In 2017

Page 3 of 11

9. Alkermes Plc (NASDAQ:ALKS)

Annual Revenue – $0.75 billion

Headquartered in Dublin, Ireland, Alkermes Plc (NASDAQ:ALKS) is a fully integrated global biopharmaceutical company, focusing on treatments for central nervous system disorders, such as schizophrenia, depression, addiction and multiple sclerosis. Alkermes Plc (NASDAQ:ALKS)’s diversified commercial product portfolio, late-stage pipeline, world-class manufacturing and strong global presence are its major advantages.

pills-530373_1920

Follow Alkermes Plc. (NASDAQ:ALKS)

Page 3 of 11